THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER

by I. A. Koroleva, M. V. Kopp
Published 2018-08-01

Fulvestrant in the treatment of luminal metastatic breast cancer: the balance of effectiveness and safety

by I. A. Koroleva, M. V. Kopp
Published 2020-07-01

POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER

by I. A. KOROLEVA, M. V. KOPP
Published 2017-06-01

Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka

by M V Kopp, I A Koroleva
Published 2009-03-01

CHEMOTHERAPY REGIMEN AC (DOXORUBICIN AND CYCLOPHOSPHAMIDE) IN BREAST CANCER – PREVENTION OF NAUSEA AND VOMITING

by I. A. Koroleva, M. V. Kopp, E. M. Lipaeva
Published 2017-11-01

Evaluation of the effectiveness of aprepitant for prevention of nausea and vomiting in patients with breast cancer

by I. A. Koroleva, M. V. Kopp, A. M. Koroleva
Published 2018-11-01

Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemot...

by P V Krivorotko, O N Burdaeva, M N Nechaeva, M A Frolova, M V Kopp, A A Abrosimova, R A Ivanov
Published 2015-06-01

Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with...

by E O Ignatova, O N Burdaeva, M V Kopp, B N Kotiv, D P Udovitsa, D L Stroiakovskii, S M Alekseev, L P Sheveleva, A V Khorinko, Iu S Shapovalova, V M Moiseenko, R A Ivanov
Published 2016-06-01